Colcrys

Formulated to alleviate acute gout attacks, indicated to target inflammation and provide relief from sudden joint pain.

Strengths: 0.5mg

Medicine details

Conditions
Alternative names

Colchimax

Therapeutic class

Anti-inflammatory agent

Pharmacological class

Tubulin inhibitor

Known off-label uses

familial mediterranean fever

Precautions and warnings

monitor for muscle pain or weakness; use with caution in elderly patients

Minor side effects

diarrhoea; nausea; vomiting; abdominal pain

Moderate side effects

fatigue; myalgia

Dosage forms

Tablet

Administration route

Oral use

Prescription status

POM

Onset Time

12–24 hours

Duration

24–48 hours

Storage instructions

Store at room temperature in a tightly closed container.

Drug interactions

clarithromycin; cyclosporin; statins

Age restrictions

Adults

Contraindications

hypersensitivity to colchicine; severe renal impairment; severe hepatic impairment

Serious side effects

rhabdomyolysis — requires immediate medical attention; pancytopenia — requires immediate medical attention

Patient summary

Formulated to alleviate acute gout attacks, indicated to target inflammation and provide relief from sudden joint pain.

Mechanism of action

Colchicine interferes with the function of microtubules in white blood cells. By inhibiting neutrophil migration and activation at the site of inflammation, it reduces the inflammatory response associated with gout crystals.

Pregnancy and breastfeeding

Pregnancy: Not recommended unless clearly necessary. Breastfeeding: Use with caution as it is distributed into breast milk.

Colcrys

Formulated to alleviate acute gout attacks, indicated to target inflammation and provide relief from sudden joint pain.

Editorial Notes

  • Active ingredient(s): Colchicine
  • Listed indication(s): Gout

Available option

  • 360 tablets - 0.5 mg802-0-5-mg-13265